The CancerTYPE ID® test is a gene expression assay that helps physicians achieve a definitive diagnosis for metastatic patients when the tumor’s origin is uncertain. The test provides increased clarity by helping resolve the following diagnostic dilemmas that impact treatment decisions: Unclear/differential diagnoses Poorly-differentiated tumors Cancers of Unknown Primary (CUP) New cancer type vs. recurrence Unusual presentations Visit the full site for more information here.

The Breast Cancer Index® (BCI™) Test is the only genomic assay recognized by the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and the ASCO® Clinical Practice Guideline to predict which patients are likely to benefit from extension of endocrine therapy beyond 5 years.1,2 Visit the full site for more information here. References: 1. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer V.4.2025. © National Comprehensive Cancer Network, Inc. 2025. All rights reserved. Accessed April 17, 2025. To view the most recent and complete version of the guideline, go online to NCCN.org. The NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. 2. Andre F et al. J Clin Oncol. Published online April 19, 2022. Referenced with permission from the American Society of Clinical Oncology (ASCO® Clinical Practice Guideline) Clinical Practice Guideline Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer. © American Society of Clinical Oncology. 2025. All rights reserved. To view the most recent and complete version of the guideline, go online to https://ascopubs.org/jco/special/guidelines [ascopubs.org].  ASCO® Clinical Practice Guideline makes no warranties of any kind whatsoever regarding their content, use of application and disclaims any responsibility for their application or use in any way.  

Panther® Scalable Solutions allows you to expand your testing menu while adding on flexibility, capacity and walkaway time. Visit the Panther® Scalable Solutions website for more information and resources.

The Panther Fusion Respiratory assays are the premier set of assays on the Panther Fusion® system. You can provide truly personalized syndromic respiratory testing with qualitative detection and differentiation of the most common respiratory viruses from a single patient sample. Visit the Panther Fusion® Respiratory Assays website for more information and resources.

The Aptima® Virology portfolio delivers on the Hologic promise of innovation through life-changing viral testing for viruses that impact patients across the globe. Visit the Aptima Virology website for more information and resources.

Visit the Hologic Virology Highlights site for more information about advocacy efforts and news highlights from the virology space.

Watch this video to learn about Hologic's ongoing commitment to quality, safety, and excellence in the manufacturing of surgical products.  

Ob/Gyn experts discuss common challenges for physicians performing global endometrial ablation, and review their experiences with the NovaSure ADVANCED system.  

Scott Schade, MD is an Ob/Gyn practicing in Spokane, WA. He has special interests in women's health care and operative gynecology.

Watch this video to learn about Hologic's ongoing commitment to quality, safety, and excellence in the manufacturing of surgical products.  

  With performance you can trust, the Panther Fusion® GBS assay transforms laboratory workflow and expands the molecular testing menu on the Panther Fusion® system. The Panther Fusion GBS assay detects Streptococcus agalactiae (GBS) in antepartum women, with demonstrated 100% sensitivity.(1) Visit the Panther Fusion® GBS assay page for more detailed information.   1. Panther Fusion GBS assay. US package insert AW-23714-001. Hologic, Inc.; 2022.

The use of fetal fibronectin (fFN) testing can help to reduce unnecessary admissions, shorten hospitalizations and help you direct care and resources to the patients who need it most. Visit the Rapid fFN Test page for more detailed information.

For over 20 years, Hologic Women’s Health Diagnostics has championed women and their health by providing essential testing for common cervical, sexual and vaginal issues. Knowing that women’s health depends on your decisions, we support you by investing in advancing care standards, access to testing and market-leading diagnostics. Visit HologicWomensHealth.com for more information.